Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar in advanced refractory cancer
NCT00079612Phase 2Completed
- Sponsor
- Bayer
- Start
- Sep 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sorafenib in cancer, renal cell carcinoma (RCC), sponsored by Bayer. Started Sep 2002; status: completed.
02
Drugs
sorafenib
03
Conditions
cancerrenal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00079612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079612.